Zanotto Filho A, Rajamanickam S, Loranc E, Masamsetti V, Gorthi A, Romero J, et al. Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells. Cancer Lett. 2018;425:101-115 pubmed publisher

Chandrasekaran S, Marshall J, Messing J, Hsu J, King M. TRAIL-mediated apoptosis in breast cancer cells cultured as 3D spheroids. PLoS ONE. 2014;9:e111487 pubmed publisher

Gandellini P, Giannoni E, Casamichele A, Taddei M, Callari M, Piovan C, et al. miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts. Antioxid Redox Signal. 2014;20:1045-59 pubmed publisher

Ogunwobi O, Wang T, Zhang L, Liu C. Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinoma. J Gastroenterol Hepatol. 2012;27:566-78 pubmed publisher

Tseng Y, Chang K, Yang C, Liu C, Kao S, Liu T, et al. Association between areca-stimulated vimentin expression and the progression of head and neck cancers. Head Neck. 2012;34:245-53 pubmed publisher

Ratovitski E. LKB1/PEA3/?Np63 pathway regulates PTGS-2 (COX-2) transcription in lung cancer cells upon cigarette smoke exposure. Oxid Med Cell Longev. 2010;3:317-24 pubmed

Nie F, Yu X, Wang X, Tang Y, Wang L, Ma L. Down-regulation of CacyBP is associated with poor prognosis and the effects on COX-2 expression in breast cancer. Int J Oncol. 2010;37:1261-9 pubmed

Liu H, Yang Y, Xiao J, Lv Y, Liu Y, Yang H, et al. COX-2-mediated regulation of VEGF-C in association with lymphangiogenesis and lymph node metastasis in lung cancer. Anat Rec (Hoboken). 2010;293:1838-46 pubmed publisher